Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium

European Journal of Pharmacology

Volumn 345, Issue 1, 1998, Pages 89-95

  Bougelet, Catherine ^a   Roland, Isabelle H ^a   Ninane, Noelle ^a   Arnould, Thierry ^a   Remacle, José ^a   Michiels, Carine ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Aescine; Endothelium; Hypoxia; Neutrophil activation; Neutrophil adherence; Reparil

Indexed keywords

ARTICLE; CHRONIC VEIN INSUFFICIENCY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOXIA; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; NEUTROPHIL; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CELL HYPOXIA; CELL LINE; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ESCIN; HUMANS; LEUKOTRIENE B4; MICROSCOPY, ELECTRON, SCANNING; NEUTROPHILS; SALICYLATES; SUPEROXIDES; UMBILICAL VEINS;

EID: 0032510505     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01616-6     Document Type: Article

References (26)

1. Annoni F., Mauri F., Marincola L., Resele F. Venotonic activity of aescine on the human saphenous vein. Drug Res. 29:1979;672-675.
2. Arnould T., Michiels C., Alexandre I., Remacle J. Effect of hypoxia upon intracellular calcium concentration of human endothelial cells. J. Cell. Physiol. 152:1992;215-221.
3. Arnould T., Michiels C., Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b and ICAM-1. Am. J. Physiol. 264:1993;C1102-C1110.
4. Arnould T., Michiels C., Remacle J. Hypoxic human umbilical vein endothelial cells induce activation of adherent polymorphonuclear leukocytes. Blood. 3:1994;3705-3716.
5. Arnould T., Michiels C., Janssens D., Delaive E., Remacle J. Hypoxia induces PMN adherence to umbilical vein endothelium. Cardiovasc. Res. 30:1995;1009-1016.
6. Arnould T., Janssens D., Michiels C., Remacle J. Effect of aescine on hypoxia-induced activation of human endothelial cells. Eur. J. Pharmacol. 315:1995;227-233.
7. Baenziger N.L., Becherer P.R., Majarus P.W. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell. 16:1979;967-974.
8. Bevilacqua M.P., Pober J.S., Wheeler M.E., Cotran R.S., Grimbrone M.A. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leucocytes, monocytes and related leucocyte cell lines. J. Clin. Invest. 76:1985;2003-2011.
9. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5:1976;9-15.
10. Browse N.L., Brunand K.G. The cause of venous ulcerations. Lancet. ii:1982;243-245.
11. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation on of human myeloid leukemia cells in suspension culture. Nature. 270:1977;347-349.
12. DeCaterina R., Dorso C.R., Tack-Goldman K., Weksler B.B. Nitrates and endothelial prostacyclin production: studies in vitro. Circulation. 71:1985;176-182.
13. Diehm C., Trampisch H.J., Lange S., Schmidt C. Comparison of leg compression stocking and oral chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet. 347:1996;292-294.
14. Gimbrone M.A. Hemodynamics, endothelial gene expression and atherogenesis. Ann. NY Acad. Sci. 811:1997;1-10.
15. Jaffe E.A. Physiologic functions of normal endothelial cells. Ann. NY Acad. Sci. 454:1985;279-291.
16. Lusher T.F. The endothelium as a target and mediator of cardiovascular disease. Eur. Clin. Invest. 23:1993;670-685.
17. McEwan A.J., McArdle C.S. Effect of hydroxyethylrutosides on blood oxygen levels and venous insufficiency symptoms in varicose veins. Br. Med. J. 2:1971;138-141.
18. McIntyre T.M., Zimmerman G.A., Satoh K., Prescott S.M. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate. J. Clin. Invest. 76:1985;271-280.
19. Michiels C., Arnould T., Knott I., Dieu M., Remacle J. Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am. J. Physiol. 264:1993;C866-C874.
20. Michiels C., Arnould T., Remacle J. Rôle-clé de l'hypoxie et des cellules endothéliales dans le développement des veines variqueuses. Med. Sci. 10:1994;845-853.
21. Michiels C., De Leener F., Arnould T., Dieu M., Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp. Cell Res. 213:1994;43-54.
22. Michiels C., Arnould T., Janssens D., Bajou K., Géron I., Remacle J. Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease. Int. Angiol. 15:1996;124-130.
23. Pober J.S., Cotran R.S. The role of endothelial cells in inflammation. Transplantation. 50:1990;537-544.
24. Rothkopf-Ischebeek, M., Vogel, G., 1980. Effect of PGE1 on plasma-lymph barrier. Official Organ of the International Society of Lymphology, Vol. 13, No. 1.
25. Stern D.M., Esposito C., Gerlach H., Gerlach M., Ryan J., Handley D., Nawroth P. Endothelium and regulation of coagulation. Diabetes Care. 14(Suppl. 1):1991;160-166.
26. Vogel G., Marek M.L., Oertner R. Studies on the mechanism of the therapeutic and toxic action of the horse chestnut saponin aescine. Arzneim.-Forsch. Drug Res. 20:1970;699-703.